Consolidated Portfolio Review Corp Clover Health Investments, Corp. Transaction History
Consolidated Portfolio Review Corp
- $796 Billion
- Q3 2025
A detailed history of Consolidated Portfolio Review Corp transactions in Clover Health Investments, Corp. stock. As of the latest transaction made, Consolidated Portfolio Review Corp holds 104,442 shares of CLOV stock, worth $257,971. This represents 0.04% of its overall portfolio holdings.
Number of Shares
104,442
Previous 37,574
177.96%
Holding current value
$257,971
Previous $105 Million
204.86%
% of portfolio
0.04%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CLOV
# of Institutions
239Shares Held
116MCall Options Held
7.3MPut Options Held
3.34M-
Vanguard Group Inc Valley Forge, PA23.1MShares$57 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA9.72MShares$24 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.54MShares$23.6 Million0.0% of portfolio
-
State Street Corp Boston, MA8.95MShares$22.1 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny7.71MShares$19.1 Million0.03% of portfolio
About CLOVER HEALTH INVESTMENTS, CORP.
- Ticker CLOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Healthcare Plans
- Shares Outstandng 383,248,000
- Market Cap $947M
- Description
- Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health In...